GlyT-1 inhibitors
US6667336B2 · kind B2 · utility
1Cited by
11References
66Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 15, 2002 |
| Grant date | Dec 23, 2003 |
| Priority date | — |
| Expiry date | Feb 15, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula: or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.